Lamivudine
Product Images NDC 10135-605
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 10135-605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1. Systemic Clearance (l/hr•kg) Of Lamivudine In Relation To (Lamivudine 02)
Figure 2. Virologic Response Through Week 48, Epv20001 (intent-to-treat) (Lamivudine 03)
Principal Display Panelndc 10135-0605-71marlexlamivudineoral Solution, Usp10 mg Per 1 mLrx Only240 mL ( 8 Ounces) (Lamivudine 04)
This is a description of "Lamivudine Oral Solution, USP" medication by Martox Pharmaceuticals that contains 10 mg of Famivuine per 1 mL. The recommended dosage information can be found on the prescribing information. The solution contains 5% alcohol and is available in a 240 mL bottle that should be stored at 20°C to 25°C. The bottle should be tightly closed and protected from light. If the safety seal around the cap of the bottle is broken or missing, do not use it. Made in the USA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.